Skip to main content
SpringerLink
Log in

The Epidemiology of Diabetic Neuropathy

  • Chapter
Diabetic Neuropathy

Part of the book series: Clinical Diabetes ((CLD))

Abstract

Peripheral neuropathy is a devastating complication of diabetes mellitus because of the debilitating symptoms it causes or associated higher risk of other complications, in particular those involving the lower extremity. This chapter will review the prevalence, incidence, and risk factors for different types of diabetic neuropathy. There are seven major types of diabetic neuropathy: (1) distal symmetric polyneuropathy, (2) autonomic neuropathy, (3) nerve entrapment syndromes, (4) proximal asymmetric mononeuropathy (also known as diabetic amyotrophy), (5) truncal radiculopathy, (6) cranial mononeuropathy, and (7) chronic inflammatory demyelinating polyradiculopathy (CIDP). This chapter will focus mainly on the first two types of neuropathy, but will review the available data on the epidemiology of the other types of neuropathy. Crosssectional or case-control studies conducted in a population-based sample (such as a defined community or health plan enrollment) were considered for this chapter based on review of Medline citations using the keywords “epidemiology,” “diabetes,” and “neuropathy” from 1966 to February 2005 review of bibliographies of the articles obtained from the Medline search for relevant citations, and review of the authors’ files. Clinic-based cross-sectional or case-control studies have not been considered except in the case of rare conditions, for which no other data exists. All prospective studies, and some randomized controlled trials, were considered. Of the five community-based cross-sectional studies reviewed of subjects with type 2 diabetes that presented data on risk factors for neuropathy, three reported a higher prevalence of this outcome with longer diabetes duration and higher glycosylated hemoglobin, and two found neuropathy prevalence correlated with age and height. Only three community-based cross-sectional studies addressed neuropathy prevalence in subjects with type 1 diabetes in association with risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rothman KJ. Modern Epidemiology. Boston: Little, Brown & Co., 1996.

    Google Scholar 

  2. Oh, S. Clinical Electromyography. Baltimore, MD: University Park, 1984.

    Google Scholar 

  3. Dyck PJ, Kratz KM, Lehman JL, et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991;41:799–807.

    PubMed  CAS  Google Scholar 

  4. Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in noninsulin-dependent diabetes mellitus. Am J Epidemiol 1990; 131:633–643.

    PubMed  CAS  Google Scholar 

  5. Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetric neuorpathy in NIDDM. Diabetes Care 1994;17:1172–1177.

    Article  PubMed  CAS  Google Scholar 

  6. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989;38:1456–1461.

    Article  PubMed  CAS  Google Scholar 

  7. Maser RE, Nielsen VK, Bass EB, et al. Measuring diabetic neuropathy. Assesssment and comparison of clincial examination and quantitative sensory testing. Diabetes Care 1989; 12:270–275.

    Article  PubMed  CAS  Google Scholar 

  8. Orchard TJ, Dorman JS, Master RE, et al. Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 1990; 13(7):741–747.

    Article  PubMed  CAS  Google Scholar 

  9. Kriska AM, Laporte RE, Patrick SL, Kuller LH, Orchard TJ. The association of physical activity and diabetic complications in indiviuals with insulin-dependent diabetes mellitus: the Epidemiology of Diabetes Complications Study—VII. J Clin Epidemiol 1991;44: 1207–1214.

    Article  PubMed  CAS  Google Scholar 

  10. Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care 1993; 16:1446–1552.

    Article  PubMed  CAS  Google Scholar 

  11. Knuiman MW, Welborn T, McCann VJ, Stanton KG, Constable IJ. Prevalance of diabetic complications in relation to risk factors. Diabetes 1986;35:1332–1339.

    Article  PubMed  CAS  Google Scholar 

  12. Walters DP, Gatling W, Mullee MA, Hill RD. The prevalence of diabetic distal sensory neuropathy in an English community. Diabet Med 1992;9:349–353.

    PubMed  CAS  Google Scholar 

  13. Bergenheim T, Borssen B, Lithner F. Sensory thresholds for vibration, perception, and pain in diabetic patients aged 15–50 years. Diabetes Res Clin Practice 1992; 16:47–52.

    Article  CAS  Google Scholar 

  14. Verhoeven S, van Ballegooie E, Casparie AF. Impact of late complications in Type 2 diabetes in a Dutch population. Diabet Med 1991;8:435–438.

    PubMed  CAS  Google Scholar 

  15. Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population >40 years of age with and without diabetes. Diabetes Care 2004;27:1591–1597.

    Article  PubMed  Google Scholar 

  16. Savettieri G, Rocca WA, Salemi G, et al. Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology 1993;43:1115–1120.

    PubMed  CAS  Google Scholar 

  17. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetolgia 1996;39:1377–1384.

    Article  CAS  Google Scholar 

  18. Anonymous, UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 1990;13:1–11.

    Google Scholar 

  19. Anonymous, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837–853.

    Article  Google Scholar 

  20. Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341–350.

    Article  PubMed  CAS  Google Scholar 

  21. Forrest KY, Maser RE, Pambianco G, Becker DJ, Orchard TJ. Hypertension as a risk factor for diabetic neuropathy. A prospective study. Diabetes 1997;46:665–670.

    Article  PubMed  CAS  Google Scholar 

  22. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral sensory neuropathy: results of the Seattle prospective diabetic foot study. Diabetes Care 1997;20:1162–1167.

    Article  PubMed  CAS  Google Scholar 

  23. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA 1984;252:1905–1907.

    Article  PubMed  CAS  Google Scholar 

  24. Dyck PJ, Davies JL, Wison DM, Service FJ, Melton LJ III, O’Brien PC. Risk factors for severity of diabetic polyneuropathy. Intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999;22:1479–1486.

    Article  PubMed  CAS  Google Scholar 

  25. Sands ML, Shetterly SM, Franklin GM, Hamman RF. Incidence of distal symmetric (sensory) neuropathy in NIDDM. Diabetes Care 1997;20:322–329.

    Article  PubMed  CAS  Google Scholar 

  26. Loyd CE, Becker D, Ellis D, Orchard TJ. Incidence of complications in insulin dependent diabetes mellitus: a survival analysis. Am J Epidemiol 1996;143:431–441.

    Google Scholar 

  27. Partanen J, Niskanen L, Lehtinen J, Mersvaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:89–94.

    Article  PubMed  CAS  Google Scholar 

  28. Klein R, Klein BE, Moss SE. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996;124(1 pt 2):90–96.

    PubMed  CAS  Google Scholar 

  29. Sosenko JM, Kato M, Soto R, Bild DE. A prospective study of sensory neuropathy in patients with Type 2 diabetes. Diabet Med 1993;10:110–114.

    PubMed  CAS  Google Scholar 

  30. Reichard P. Risk factors for progression of microvascular complications in the Stockholm Diabetes Intervention Study (SDIS). Diabetes Res Clin Practice 1992;16:151–156.

    Article  CAS  Google Scholar 

  31. Maser RE, Becker DJ, Drash AL, et al. Pittsburgh Epidemiology of Diabetes Complications Study. Measuring diabetic neuropathy follow-up study results. Diabetes Care 1992; 15: 525–527.

    Article  PubMed  CAS  Google Scholar 

  32. Hillson RM, Hockaday T, Newton DJ. Hyperglycemia is one correlate of deterioration in vibration sense during the 5 years after diagnosis of Type 2 (non-insulin-dependent) diabetes. Diabetolgia 1984;26:122–126.

    CAS  Google Scholar 

  33. Ziegler D, Mayer P, Muhlen H, Gries FA. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycemic control during the first five years after the diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetolgia 1991;34: 822–829.

    Article  CAS  Google Scholar 

  34. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978;1:168–188.

    Google Scholar 

  35. Singh JP, Larson M, O’donnell CJ, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000;86:309–312.

    Article  PubMed  CAS  Google Scholar 

  36. Maser RE, Pfeifer M, Dorman JS, Kuller LH, Becker DJ, Orchard TJ. Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 1990;150:1218–1222.

    Article  PubMed  CAS  Google Scholar 

  37. Group, T.D.C.a.C.T.E.o.D.I.a.C.R. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122:561–568.

    Google Scholar 

  38. Toyry JP, Niskanen LK, Mantysaari MJ, Lansimies EA, Uusitupa MIJ. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten year follow-up from diagnosis. Diabetes Care 1996;45:308–315.

    CAS  Google Scholar 

  39. Gaede P, Vedel P, Larsen N, Jensen G, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348: 383–393.

    Article  PubMed  Google Scholar 

  40. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43(4):817–824.

    PubMed  CAS  Google Scholar 

  41. O’Hare JA, Abuaisha F, Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir J Med Sci 1994;163(3):132–135.

    Article  PubMed  CAS  Google Scholar 

  42. Albers JW, Brown MB, Sima AA, Greene DA. Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT). Tolrestat Study Group For Edit (Early Diabetes Intervention Trial). Muscle Nerve 1996; 19(2): 140–146.

    Article  PubMed  CAS  Google Scholar 

  43. Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 2002;25(3):565–569.

    Article  PubMed  Google Scholar 

  44. de Krom MC, Kester AD, Knipschild PG, Spaans F. Risk factors for carpal tunnel syndrome. Am J Epidemiol 1990;132(6):1102–1110.

    PubMed  Google Scholar 

  45. Solomon DH, Katz JN, Bohn R, Mogun H, Avorn J. Nonoccupational risk factors for carpal tunnel syndrome. J Gen Intern Med 1999;14:310–314.

    Article  PubMed  CAS  Google Scholar 

  46. Becker J, Nora DB, Gomes I, et al. An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clin Neurophysiol 2002; 113(9): 1429–1434.

    Article  PubMed  Google Scholar 

  47. Karpitskaya, Y, Novak CB, Mackinnon SE. Prevalence of smoking, obesity, diabetes mellitus, and thyroid disease in patients with carpal tunnel syndrome. Ann Plast Surg 2002;48(3): 269–273.

    Article  PubMed  Google Scholar 

  48. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991;41(5):617–618.

    Google Scholar 

  49. Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 1999;66(5):677–680.

    PubMed  CAS  Google Scholar 

  50. McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999;46(6):910–913.

    Article  PubMed  CAS  Google Scholar 

  51. Sharma KR, Cross J, Farronay O, et al. Demyelinating neuropathy in diabetes mellitus. Arch Neurol 2002;59(5):758–765.

    Article  PubMed  Google Scholar 

  52. Lozeron P, Nahum L, Lacroix C, Ropert A, Guglielmi JM, Said G. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol 2002;249(5): 569–575.

    Article  PubMed  Google Scholar 

  53. McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 1995;18(2):216–219.

    Article  PubMed  CAS  Google Scholar 

  54. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998; 158(2): 157–162.

    Article  PubMed  CAS  Google Scholar 

  55. Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care 1992;15(10):1386–1389.

    Article  PubMed  CAS  Google Scholar 

  56. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994;17(6):557–560.

    Article  PubMed  CAS  Google Scholar 

  57. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 2000;23(5):606–611.

    Article  PubMed  CAS  Google Scholar 

  58. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999;22(7):1036–1042.

    Article  PubMed  CAS  Google Scholar 

  59. Eriksson KF, Nilsson H, Lindgarde F, et al. Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabetes Med 1994; 11:279–285.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. VA Puget Sound Health Care System, Seattle, WA

    Stephanie Wheeler MD, MPH, Nalini Singh MD & Edward J. Boyko MD, MPH

Authors
  1. Stephanie Wheeler MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nalini Singh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Edward J. Boyko MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Aristidis Veves MD, DSc

  2. Manchester Royal Infirmary and University of Manchester, Manchester, UK

    Rayaz A. Malik MBChB, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Wheeler, S., Singh, N., Boyko, E.J. (2007). The Epidemiology of Diabetic Neuropathy. In: Veves, A., Malik, R.A. (eds) Diabetic Neuropathy. Clinical Diabetes. Humana Press. https://doi.org/10.1007/978-1-59745-311-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-311-0_2

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-626-9

  • Online ISBN: 978-1-59745-311-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation